Capivasertib (AZD5363)
Capivasertib (AZD5363) 是一种强效的 AKT 抑制剂,在体内具有药效活性,有潜力作为单药治疗或联合治疗药物,用于治疗多种实体瘤和血液肿瘤。
Capivasertib (AZD5363) 是一种强效的 AKT 抑制剂,在体内具有药效活性,有潜力作为单药治疗或联合治疗药物,用于治疗多种实体瘤和血液肿瘤。
| Discription | Capivasertib (AZD5363) is a potent inhibitor of AKT with pharmacodynamic activity in vivo, has potential to treat a range of solid and hematologic tumors as monotherapy or a combinatorial agent. |
|||||
|---|---|---|---|---|---|---|
| Targets |
|
|||||
| Cell Research |
|
| 目录号 | A11759 |
|---|---|
| 分子式 | C21H25ClN6O2 |
| 分子量 | 428.9 |
| CAS号 | 1143532-39-1 |
| SMILES | C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4 |
| 其他名称 | AZD 5363, AZD-5363 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 79 mg/mL (184.18 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.32 mL | 116.58 mL | 233.15 mL |
| 0.5 mM | 4.66 mL | 23.32 mL | 46.63 mL |
| 1 mM | 2.33 mL | 11.66 mL | 23.32 mL |
| 5 mM | 0.47 mL | 2.33 mL | 4.66 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2